Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
Orchestra BioMed Holdings, Inc. has been added to the Russell 3000 and Russell 2000 indexes following the 2026 Russell index reconstitution. This inclusion reflects the company's market capitalization growth and positions it among the leading U.S. small-cap stocks. Orchestra BioMed is advancing two innovative biomedical treatments addressing hypert…
DeFi Development Corp. announced that its UK affiliate, DeFi Development Corporation UK PLC, is no longer affiliated with its treasury accelerator strategy and has terminated their revolving credit facility. The UK entity plans to rebrand to Cykel AI PLC and pursue artificial intelligence. DeFi Development Corp. continues its focus on accumulating …
Nasdaq has halted trading in Happy City Holdings Ltd (ticker: HCHL) pending the company's provision of additional information, following an earlier suspension of trading by the SEC. The last share price was $3.96 before the halt. The suspension period ran from June 12 to June 29, 2026. Trading will remain halted until Nasdaq's information requests …
Rani Therapeutics has named Nicholas Maestas as its new Chief Financial Officer, effective immediately. Maestas brings over a decade of financial leadership experience in biopharma, having led significant financing transactions and strategic initiatives at previous companies. The appointment follows the departure of former CFO Svai Sanford. Rani Th…
4D Molecular Therapeutics announced early and over-enrollment completion of their global Phase 3 4FRONT-2 trial testing 4D-150 for wet age-related macular degeneration (wet AMD). This underscores strong clinical interest and supports 4D-150 as a potential breakthrough durable therapy reducing treatment burden in wet AMD. Topline data is expected in…
Ascent Solar Technologies announced successful preliminary atomic oxygen exposure testing of its flexible thin-film photovoltaic solar products designed for space use. Testing simulating six months of exposure at International Space Station altitude showed zero power loss, demonstrating high resilience to a key space environment challenge. This adv…
Insight Molecular Diagnostics Inc. announced that Chief Science Officer Dr. Ekkehard Schuetz has published his 200th scientific paper, cementing his leadership in molecular diagnostic testing for transplanted organ rejection. Dr. Schuetz co-invented the key dd-cfDNA technology behind iMDx's GraftAssure product line. Under his leadership, the compan…
Village Farms International, Inc. announces the launch of the WK Duo-Pack, a limited-edition pre-roll duo-pack featuring Tangerine flower and custom orange branding, exclusively available through licensed coffeeshop partners in the Netherlands. This activation leverages Dutch football culture during the Wereldkampioenschap (World Championship) to d…
Ocean Power Technologies, Inc. has amended and restated its Section 382 Tax Benefits Preservation Plan to extend the plan's expiration from June 29, 2026, to June 29, 2029. The plan aims to protect the company's federal net operating loss carryforwards (NOLs) by reducing the likelihood of an ownership change that could limit their use, by deterring…
Swarmer, Inc. announced an update to its contract via Meta Bureau LLC, expanding the SkyKnight software license purchases to Czech-based Progress TRW S.R.O. This results in an additional $1.02 million revenue recognition and increases the total potential contract value to $14.20 million. The expansion strengthens Swarmer's presence in European defe…
LanzaTech Global, Inc., a carbon management solutions company trading on NASDAQ under the ticker LNZA, announced its inclusion in the Russell 3000® Index effective June 29, 2026. This inclusion also places it in the Russell 2000® small-cap index, increasing the company's visibility among institutional investors and potentially broadening its invest…
Roadzen Inc. reported its strongest quarter in company history with Q4 FY2026 revenue of $16.1 million, a 42% year-over-year increase, and record full-year revenue of $55.0 million, up 24%. The company's net loss narrowed by 69%, with adjusted EBITDA losses decreasing for the seventh consecutive quarter, nearing breakeven. Roadzen's AI-powered insu…
XMax Inc., a NASDAQ-listed company specializing in AI infrastructure and contemporary furniture, has been added to the Russell 3000® Index, representing the largest 3,000 U.S. companies. This inclusion highlights the company's strategic transformation and strengthening financial position, supported by its expansion into AI offerings and established…
TryHard Holdings Limited, a Nasdaq-listed lifestyle entertainment company in Japan, announces the expansion of its flagship cultural programming brand, Music Circus, supported by majority shareholder SBI Holdings. The company highlights successful large-scale events such as the SBI Fireworks Festival, attracting over 25,000 attendees, and previews …
Replimune Group, Inc. reported its fiscal Q4 and full-year 2026 financial results and provided a corporate update highlighting the FDA's acceptance of the Biologics License Application (BLA) resubmission for RP1 in combination with nivolumab for advanced melanoma with a target decision date of August 2, 2026. The company presented encouraging long-…
Abundia Global Impact Group, Inc., a low-carbon energy solutions company listed on NYSE American under the ticker AGIG, announced its inclusion in the Russell Microcap® Index effective June 29, 2026. This inclusion follows the company's recent business transformation and public listing, representing a notable milestone. Being part of the Russell Mi…
Mdxhealth SA announced the peer-reviewed publication of the Oxford GPS-ProMPT study in European Urology Oncology, establishing significant scientific validation for its GPS mdx genomic prostate cancer test. This study's findings underpin the ongoing GPS-ProtecT randomized controlled trial, aimed at proving GPS mdx as the first genomic classifier va…
Clearmind Medicine Inc., a clinical-stage biotech company specializing in neuroplastogen-derived therapeutics for under-treated health issues, announced the issuance of a new U.S. patent (No. 12,357,590) related to regulating binge behaviors. This patent builds on previous patents covering the MEAI molecule and related compounds, expanding the comp…
VivoPower PLC has chosen a preferred global AI industry leader as the long-term tenant for its Mo i Rana AI data center in Norway. The company is finalizing legal agreements expected to be announced soon, with potential expansions and further collaboration across its powered land infrastructure pipeline. The Mo i Rana data center operates on 100% r…
Helus Pharma reported fiscal year 2026 financial results and significant clinical progress, highlighting over 88% enrollment in the Phase 3 APPROACH study for HLP003 in Major Depressive Disorder, pending topline data in Q4 2026. The company secured $50 million in an underwritten offering to support its second Phase 3 trial, EMBRACE, aiming for a po…
BrainsWay Ltd. presented positive new real-world data from a retrospective study of 462 patients showing that Deep Transcranial Magnetic Stimulation (Deep TMS) significantly reduces symptoms in patients with comorbid PTSD and major depressive disorder (MDD). Results demonstrated an 83.5% response rate in PTSD symptom reduction and a 66.6% response …
Xilio Therapeutics, a clinical-stage biotech company focused on masked immuno-oncology therapies, announced the appointment of Ben Harshbarger as Chief Legal Officer. Harshbarger brings over 20 years of legal and executive experience in the biopharmaceutical sector and will support Xilio's strategic and operational goals as it advances multiple can…
Kailera Therapeutics, a clinical-stage biotech focused on obesity treatments, has appointed Kathleen Tregoning as Chief Corporate Affairs Officer. With extensive experience in biopharma corporate affairs, Tregoning will support Kailera's strategic efforts to navigate the evolving obesity treatment landscape and advance its pipeline. Kailera's lead …
Palvella Therapeutics has submitted the first module of its rolling New Drug Application (NDA) to the FDA for QTORIN™ 3.9% rapamycin anhydrous gel intended to treat microcystic lymphatic malformations (LMs). The FDA has granted the drug Breakthrough Therapy, Fast Track, and Orphan Drug designations signaling an expedited review process due to the d…
Streamex Corp. announced a collaboration with Siebert Financial and tZERO that allows its gold-backed, yield-bearing tokenized security GLDY to be purchased through traditional brokerage accounts. This partnership integrates blockchain-based securities with conventional financial distribution networks, making it easier for accredited and institutio…
